Skip to main content

CONGRESS ASSET MANAGEMENT CO

Position in NBIX — Neurocrine Biosciences Inc

CIK 897378 BOSTON, MA

Position in NBIX

as of Jun 30, 2026 · filed Jul 7, 2026
Position Value
$13,902,190
+$13,524,568 QoQ
Shares Held
82,486
+2966.4% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#3
of 28 holders
Holding Since
Sep 2020
17 quarters on record
Voting authority Sole 99.90786315253497.ToString("F0")% Shared 0.ToString("F0")% None 0.09213684746502437.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CONGRESS ASSET MANAGEMENT CO holds $29,146,248 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (47.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
82,486 $13,902,190

All Filings in NBIX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,902,190 82,486
2025-09-30 $377,622 2,690
2025-03-31 $261,347 2,363
2024-06-30 $393,047 2,855
2023-09-30 $475,762 4,229
2023-06-30 $544,299 5,772
2023-03-31 $93,127,764 920,053
2022-12-31 $109,625,018 917,825
2022-09-30 $116,212,539 1,094,177
2022-06-30 $104,678,118 1,073,842
2022-03-31 $104,142,000 1,110,848
2021-12-31 $77,427,024 909,088
2021-09-30 $97,039,052 1,011,772
2021-06-30 $92,314,345 948,565
2021-03-31 $87,703,356 901,834
2020-12-31 $72,936,194 760,941
2020-09-30 $73,817,224 767,650